Publications by authors named "H Lode"

Claim this Profile
[
[Correction: Development of a standardized handover for critically ill premature and newborn infants for interhospital transport in Bavaria].
Janik Wolff, Christian Batzlsperger, Christian Brickmann, Peter Dahlem, Heinrich Eberhardt, Hans-Martin Lode

Z Geburtshilfe Neonatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-label Use of Dinutuximab Beta in Combination With Chemotherapy in Patients With Ewing Sarcoma: A Retrospective Single-center Case Series.
Neofit J Spasov, Frank Dombrowski, Holger Lode

J Pediatr Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK inhibitors promote neuroblastoma cell differentiation and increase sensitivity to retinoic acid-a promising combination strategy for therapeutic intervention.
Fatemeh Shokraie, Larissa Lechermeier, Pia Bordihn, Philipp Kaps, Steffen Möller, Holger N Lode

Cell Death Discov· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison.
Holger N Lode, Przemysław Holko, Aleksandra Wieczorek, Nikolai Siebert, Dominique Valteau-Couanet

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition.
Sascha Troschke-Meurer, Maxi Zumpe, Peter Moritz Ahrenberg, Torsten Ebeling, Nikolai Siebert, Holger N Lode

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis